|
December 15, 2006
CELL BIOLOGY: Protein Appears to Be Keeper
of the Female Germ Line
To become a fully viable egg, oocytes must divide twice, and yet they essentially
stop all activity before the first division. Most will remain in this state of
suspended animation for decades, during which they are highly susceptible to
DNA damage through radiation. Researchers have suspected that during this period
of meiotic arrest, egg cells must have some way of detecting and, possibly, repairing
or eliminating cells with damaged DNA. Other cells depend on the famous protein
p53. It turns out that in oocytes, the job is carried out by a closely related
protein, p63. These findings, reported by (clockwise from left) Arminia Kettenbach,
Christopher Crum, Eun-Kyung
Suh, Frank McKeon, and colleagues in the Nov. 30 Nature, could
pave the way to a new understanding and, perhaps, treatment of some forms of
infertility. |
|
CARDIOVASCULAR RESEARCH: Precursor Pinpointed that Generates Heart Cells
Two new studies fuel hope that scientists may one day be able to identify stemlike
cardiac cells in humans for patching or replacing damaged heart tissue. The independent
studies, appearing in the Dec. 15 Cell, were conducted in the labs of
Kenneth Chien (pictured) and Stuart Orkin. The teams report that a single
type of “master” cell in developing mice can morph into the two or
three major kinds of heart cell—cardiac myocytes, smooth muscle cells,
and, in one study, endothelial cells.
|
ONCOLOGY: Basis of Action Found for
Anti-inflammatories’ Anticancer Role
A growing number of epidemiological studies show that nonsteroidal anti-inflammatory
drugs protect against a variety of cancers, including prostate, breast, and ovarian.
But exactly how these drugs keep cancer cells in check is unclear. In the December Cancer
Research, Towia Libermann (right), Luiz Zerbini, and colleagues report that
several of these anti-inflammatories induce expression of interleukin 24 in cultured
cancer cells. The interleukin has dual effects on the cells, turning up expression
of proteins that stimulate programmed cell death and put a brake on the cell
cycle. The findings may help researchers identify anticancer drugs and improve
disease therapies.
|